A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial

J Am Coll Cardiol. 2009 Mar 3;53(9):812-3. doi: 10.1016/j.jacc.2008.11.028.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Coronary Restenosis / etiology
  • Coronary Restenosis / mortality
  • Coronary Restenosis / prevention & control*
  • Diabetes Mellitus / physiopathology*
  • Drug-Eluting Stents*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Paclitaxel / therapeutic use*
  • Risk Factors
  • Sirolimus / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Phytogenic
  • Immunosuppressive Agents
  • Paclitaxel
  • Sirolimus